Araceli Biosciences
- Other products or services
- Medical device or technology
Araceli Biosciences builds ultra-high throughput imaging systems and real-time analysis software that accelerate drug discovery. Our Endeavor platform delivers 50x faster high-content imaging, enabling both traditional HTS and emerging TechBio workflows like CRISPR screens, multimodal assays, and AI-driven lab-in-the-loop platforms. First users came online in 2023, and we’re seeing strong commercial growth through 2024 and into 2025. Araceli is already in use by large pharma and next-gen platform companies. We’re actively seeking business development partners pioneering new discovery models, as well as collaborators and investors as we scale our commercial operations.